ZetaDisplay: Finalizes the acquisition of ProntoTV in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ZetaDisplay: Finalizes the acquisition of ProntoTV in Norway

Sweden, 2016-09-28 14:40 CEST (GLOBE NEWSWIRE) --  

ZetaDisplay has today completed the acquisition of ProntoTV in Norway. This acquisition is in accordance with the agreement that was signed with the vendors on 22 August 2016.

ZetaDisplay Norway and ProntoTV will merge during the fourth quarter and in future operate with the name ProntoTV “a part of ZetaDisplay” on the Norwegian market.   Ola Sæverås will be the MD for the merged business.

The acquisition is a further step in ZetaDisplay’s goal to establish itself as a leading supplier of Digital Signage on the European market. Together with ZetaDisplay’s existing operations in Norway, the merged operations will have a more leading position with a very strong customer base. ProntoTV’s customer base includes, among others, Reitan Group, Sparebank1, JCDecaux, Avinor, Norway Post, Vita and Boots Pharmacy. Through the acquisition, ZetaDisplay will significantly increase its growth and continue to be an active participant in the consolidation of its industry.

The acquisition of ProntoTV is to take place by ZetaDisplay acquiring all shares in ProntoTV by means of a cash payment and a directed share issue to the seller, Pronto Holding AS, of 1 million ordinary shares of ZetaDisplay AB (publ). As previously communicated in a press release 25 August 2016, ZetaDisplay has issued 1 000 000 ordinary shares as part of the purchase price for ProntoTV AS. All 1 000 000 ordinary shares have today been subscribed for and allocated to Pronto Holding AS at a subscription price of SEK 8 per ordinary share, corresponding to issue proceeds of MSEK 8. All newly-issued shares will be registered during October 2016.

 

For more information please contact:

ZetaDisplay AB (publ)

CEO Leif Liljebrunn

Telephone: +46 70 845 80 52

E-mail: leif.liljebrunn@zetadisplay.com

The information contained in this press release is the type of information which ZetaDisplay is obligated to publish according to the Market Abuse Regulation. The information was caused to be published by Leif Liljebrunn on 28 September 2016 at 14:40 PM.

About ZetaDisplay

ZetaDisplay is a leading supplier of Digital Signage to major chains in the retailing and service sectors of the European market. The head office is in Sweden and there are sales offices located in Denmark, Norway, Finland, Estonia and the Netherlands. Since April 2011 the company’s shares have been traded on NASDAQ OMX First North Premier, using the ZETA abbreviation. The Certified Adviser is Erik Penser Bank. More information can be found at  http://www.zetadisplay.com

About Digital Signage and multi-channel communication

ZetaDisplay defines Digital Signage as a system for advertising, profiling and retail store communication, which forwards audio, images and film related to retail stores and information in the public environment. A Swedish name for Digital Signage translates as digital retailing communications. Solutions based on digital displays form a large part of the market, but development is proceeding towards the utilisation of more digital channels to communicate customer offers and other information. This is a matter of solutions that are integrated into social media and web sites, and apps for smart mobile phones and tablets which create interaction with customers. Development is also progressing towards integrating solutions with retailers’ cash desks for automatic price updating and the automatic switching of offers on the digital displays.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading